CNSX:TRULPharmaceuticals
Assessing Trulieve Cannabis (CNSX:TRUL) Valuation After NYSE Listing And Schedule III Rescheduling
NYSE listing and regulatory shift put Trulieve Cannabis (CNSX:TRUL) in focus
Trulieve Cannabis (CNSX:TRUL) is back on investors’ radar after its subordinate voting shares were cleared to list on the New York Stock Exchange, following the federal move to classify medical marijuana as Schedule III.
See our latest analysis for Trulieve Cannabis.
Recent price action has been intense, with a 19.2% 1 day share price return and an 80.8% 90 day share price return as the NYSE listing and regulatory...